About Index Trending news
Analyze
Top 50 Pricing
ZIOPHARM Oncology

ZIOPHARM Oncology

Work at ZIOPHARM Oncology? Add yourself to this profile

ZIOPHARM Oncology

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$120,000,000
Post-IPO equity
$57,500,000
Employees

Unknown size

Locations
HQ
Xconomy

Ziopharm Discloses Patient Death in Brain Cancer Trial, Shares Fall

The Motley Fool

Better Buy: Ziopharm Oncology, Inc. vs. Celgene

The Motley Fool

Here's How Ziopharm Oncology Hopes to Win the CAR-T Race

The Motley Fool

Why Ziopharm Oncology Soared 49% In February

The Motley Fool

Why ZIOPHARM Oncology Inc. Published a Higher Stock Price Today